Emil T. Kuriakose
Corporate Officer/Principal bei TERNS PHARMACEUTICALS, INC.
Vermögen: 272 684 $ am 30.04.2024
Aktive Positionen von Emil T. Kuriakose
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2023 | - |
Karriereverlauf von Emil T. Kuriakose
Ehemalige bekannte Positionen von Emil T. Kuriakose
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2013 | 01.01.2016 |
CALITHERA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 | - |
Ausbildung von Emil T. Kuriakose
Stony Brook University School of Medicine | Doctorate Degree |
New York University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CALITHERA BIOSCIENCES, INC. | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Börse
- Insiders
- Emil T. Kuriakose
- Erfahrung